.svg){kind=icon}
Across the industry, sponsors are re-evaluating traditional CRO and FSP engagement models. Rather than defaulting to large, all-encompassing partnerships, teams are increasingly prioritizing flexibility—bringing in the right expertise at the right moment to address specific operational, quality, or oversight needs.
This shift reflects a broader focus on impact over scale, with sponsors seeking experienced leadership that can adapt as studies evolve.
As trial complexity increases, many organizations are finding that targeted, flexible support models offer greater control and an efficient use of resources throughout the study lifecycle.
Ascendia FLEX™ was designed with this reality in mind—providing scalable, right-sized leadership and operational support aligned to each study’s specific needs and inflection points.
Leesa Gentry is Chief Clinical Officer at RenovoRx, with nearly 30 years of experience leading clinical research across pharma, biotech, and CROs.
Having held senior roles at Evotec, PPD, OmnicareCR, and Otsuka, Leesa brings a rare, end-to-end perspective on trial execution.
We had the great honor of hosting Leesa on The Clinical Current podcast, where she shared practical insights sponsors can apply immediately.
In our latest episode of The Clinical Current, we sat down with Leesa Gentry for a practical conversation on trial execution and leadership.
Together, we explored what trial execution looks like beyond theory—how decisions actually get made under pressure, where operational friction shows up first, and why leadership and focus matter more than ever.
Up next, we’ll continue the discussion with a roundtable episode featuring QACV, exploring quality, oversight, and execution from multiple perspectives.
Across the industry, sponsors are re-evaluating traditional CRO and FSP engagement models. Rather than defaulting to large, all-encompassing partnerships, teams are increasingly prioritizing flexibility—bringing in the right expertise at the right moment to address specific operational, quality, or oversight needs.
If you’re responsible for protecting timelines, quality, and decision-making across a study, our recent three-part blog series was written with you in mind.
Thank you for being part of the Ascendia Clinical community. We’re grateful to work alongside sponsors, partners, and industry leaders who share a commitment to thoughtful execution, clear decision-making, and progress across clinical development. Your engagement and perspective continue to shape the conversations we focus on and the insights we share.
Ascendia Clinical delivers expert consulting solutions for the Biotechnology and Pharmaceutical industries, with a focus on integrity, collaboration, and results. Partner with us for tailored strategies that drive your success.
